Rinascera Therapeutics
PrivateLast Round
VC Round
Jul 16, 2026
Total Funding Raised
$2.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rinascera Therapeutics is a biotechnology company that develops transformative therapies for patients living with rare genetic skin diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rinascera Therapeutics Comparables
Compare Rinascera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RHEACELL GmbH & Co. KG | 77% | |
| Aegle Therapeutics Corp | 75% | |
| Kamal Therapeutics, Inc. | 65% |
Rinascera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 16, 2026 | ||||
| Seed | Oct 8, 2025 |
Rinascera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Toba Capital | VC Round |
| Civilization Ventures | VC Round |
| Double Point Ventures | Seed, VC Round |
| Olive Tree Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
VC Round led by Double Point Ventures with participation from Civilization Ventures, Olive Tree Capital, and Toba Capital.
- Oct 8, 2025
$3M round led by Double Point Ventures.
Rinascera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rinascera Therapeutics's valuation, stock price, and market status.
Is Rinascera Therapeutics a public or private company?
Rinascera Therapeutics is a private company.
What is the current stock price of Rinascera Therapeutics?
Rinascera Therapeutics is a private company with no public stock price. Caplight tracks Rinascera Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Rinascera Therapeutics worth (valuation)?
Valuation information for Rinascera Therapeutics is not publicly available.
Can I buy Rinascera Therapeutics stock?
Rinascera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rinascera Therapeutics's last funding round?
Rinascera Therapeutics's most recent funding round was VC Round on July 16, 2026.
Who are the main investors in Rinascera Therapeutics?
Key investors in Rinascera Therapeutics include Double Point Ventures.
Will Rinascera Therapeutics IPO soon?
No public IPO plans have been announced for Rinascera Therapeutics.
How can I track Rinascera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rinascera Therapeutics's secondary market activity and sign up for updates.